Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by MedStocks2on Aug 30, 2019 4:14pm

43 Views

Post# 30084678

RE:House Positions and Market Summary 29-8-2019

You do realize that a trade at the OTC can be someone selling shares to a buyer in Canada rather that a buyer right. The shares dont actually exist in the OTC it is only a clearing agent for someone in the USA to buy or sell shares in Canada. Also, many brokerages in the USA actually offer trading directly on foreign exchanges so it is a bit pointless to try and comment on whether there are any buyers or sellers from the zUS on any given day.

Bullboard Posts

5 steps to mastering risk management in the stock market